CSIMarket
 
Healthcare Sector

Laboratory Analytical Instruments Industry  




Data by Company within Laboratory Analytical Instruments Industry


  Marketcap Revenues (TTM) Net Income (TTM) Employees
Company (Millions) (Millions) (Millions) Number
Agilent Technologies inc $ 43,234 $ 6,833 $ 1,240 18,100
Mettler toledo International Inc $ 28,699 $ 3,788 $ 789 17,800
Illumina Inc $ 20,204 $ 4,504 $ -1,161 9,800
Avantor Inc $ 17,134 $ 6,967 $ 321 -
Bruker Corporation $ 13,566 $ 2,818 $ 322 6,900
Bio rad Laboratories Inc $ 9,741 $ 2,671 $ -637 7,900
10x Genomics Inc $ 4,277 $ 564 $ -248 1,500
Olink Holding Ab publ $ 2,796 $ 95 $ -38 267
Quanterix Corp $ 998 $ 122 $ -32 359
Pacific Biosciences Of California Inc $ 961 $ 200 $ -307 500
Cytek Biosciences Inc $ 938 $ 192 $ -12 300
Eyepoint Pharmaceuticals Inc $ 824 $ 43 $ -100 -
Prenetics Global Limited $ 357 $ 276 $ -190 -
Nautilus Biotechnology Inc $ 320 - $ -64 -
Scientific Industries Inc $ 213 $ 11 $ -8 739
Standard Biotools Inc $ 207 $ 105 $ -76 -
Akoya Biosciences Inc $ 200 $ 90 $ -71 -
Harvard Bioscience Inc $ 173 $ 112 $ -3 289
Seer Inc $ 127 $ 16 $ -91 -
Phenomex Inc $ 99 $ 72 $ -125 -
Kewaunee Scientific Corporation $ 95 $ 198 $ 9 1,357
Rapid Micro Biosystems Inc $ 42 $ 21 $ 29 -
Singular Genomics Systems Inc $ 37 $ 3 $ 89 -
Bionano Genomics Inc $ 35 $ 34 $ -227 -
Cue Health Inc $ 30 $ 71 $ -373 51
Isoplexis Corporation $ 30 $ 17 $ -106 -
Talis Biomedical Corporation $ 17 $ 2 $ -75 -
Astrotech Corp $ 14 $ 1 $ -10 42
Accelerate Diagnostics Inc $ 14 $ 10 $ -63 -
Precipio inc $ 9 $ 13 $ -9 -
Lifeloc Technologies Inc $ 7 $ 9 $ 0 -
Reflect Scientific Inc $ 6 $ 1 $ 0 -
Pressure Biosciences Inc $ 3 $ 2 $ -26 -
Thermogenesis Holdings Inc $ 2 $ 8 $ -15 -
Htg Molecular Diagnostics Inc $ 1 $ 6 $ -20 -
Perkinelmer Inc - $ 6,939 $ 1,261 -
Codex Dna Inc - $ 7 $ -19 -
Laboratory Analytical Instruments Industry $ 145,408 $ 36,820 $ -50 65,904
  Recent News from Laboratory Analytical Instruments Industry
Shares

Standard BioTools Simplifies Capital Structure with Exchange of Series B Convertible Preferred Stock

Standard BioTools Announces Exchange of Series B Convertible Preferred Stock for Common Stock
SOUTH SAN FRANCISCO, Calif., March 18, 2024 - Standard BioTools Inc. (Nasdaq: LAB) made an announcement today regarding the exchange of all outstanding shares of its Series B Convertible Preferred Stock for common stock. This exchange was made possible throug...

Cytek Biosciences Inc

Cytek Biosciences Inc. Surges in Revenue, Defying Market Trends

CTKB, the leading cell analysis solutions company, has reported strong financial results for the fourth quarter and fiscal year 2023. The company showcased impressive growth, with income per share rising by 101.19% year on year to $0.04 per share and revenue increasing by 22.058% to $59.00 million.
This growth is particularly noteworthy considering th...

Cue Health Inc

Cue Health Inc Faces Challenges Amid Declining Revenue and Inventory Decrease



The Laboratory Analytical Instruments company recently announced its financial results for the fiscal year ending December 31, 2023. The report highlighted a significant decline in revenue and a widening shortfall per share compared to the previous reporting season. Additionally, Cue Health Inc, a related company, also reported a substantial net...

Products & Services

Unlocking the Future of Cellular Exploration: 10x Genomics Redefines Single Cell Analysis with Chromium GEM-X

In a groundbreaking development, leading innovator in single cell and spatial biology, 10x Genomics, has announced the commercial availability of its highly anticipated Chromium GEM-X products. This next generation of their renowned single cell technology architecture promises to revolutionize the field by enhancing performance, scalability, and cost-effe...

Kewaunee Scientific Corporation

Company Weathered Revenue Contraction with Resilience in Recent Financial Report

The stock market is a dynamic and ever-changing landscape, with companies constantly striving to improve their financial standing and deliver value to their shareholders. In this regard, KEQU, also known as Kewaunee Scientific Corporation, has recently announced some truly astonishing income improvements.
According to their third-quarter financial rep...

Harvard Bioscience Inc

Harvard Bioscience Inc Reports Mixed Results in Fourth Quarter of 20232.

Harvard Bioscience Inc, a leader in the Laboratory Analytical Instruments industry, recently released its financial results for the fourth quarter of 2023. While the company reported a surge in its deficit per share and a slight increase in revenue, it also noted a decline in operating earnings and an increase in net deficit. These results have raised que...

Product Service News

Cytek Biosciences Expands Operations in China to Cater to Rising Global Demand for Advanced Cell Analysis Solutions

Cytek Biosciences, a leading provider of innovative cell analysis solutions, has recently inaugurated a state-of-the-art 50,000-square-foot facility in Wuxi, China. This expansion aims to meet the escalating demand for cutting-edge cell analysis technology worldwide. With its increased manufacturing and research capabilities, Cytek Biosciences is poised t...

Product Service News

Harvard Bioscience Unveils Groundbreaking Solutions for Preclinical and Organoid Applications, Paving the Way for Unprecedented Research Efficiency and Data Analytics Advancements.

Harvard Bioscience to Showcase Cutting-Edge Solutions for Preclinical Advancements and Organoid Applications, Revolutionizing Research Efficiency and Data Analytics in CROs, Pharma, and BiotechsBoston, MA - March 12, 2021Harvard Bioscience, a world-renowned provider of innovative solutions for life science research, is set to unveil its latest breakthroug...

Product Service News

Quanterix's Breakthrough Blood-Based p-Tau 217 Test Receives FDA Designation for Alzheimer's Disease Diagnosis

Quanterix Corporation, a leading provider of ultra-sensitive research products and high-definition diagnostics, has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) for its Simoa phospho-Tau 217 (p-Tau 217) blood test. This groundbreaking designation marks a significant achievement in the field of Alzheimer's Disea...

Pacific Biosciences Of California Inc

Pacific Biosciences Of California Inc's Remarkable Revenue Growth Raises Concerns About Operational Efficiency

As a Wall Street journalist, it is important to analyze and dissect the financial performance of companies to provide investors with valuable insights. In the case of Pacific Biosciences Of California Inc, the recent announcement of very solid revenue growth of 113.622% year on year to $58.43 million in the October to December 31, 2023 three months is ind...







Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com